Lundbeck: Employers show an interest in alcohol pill
It requires sound scientific data and a strong initial effort to convince a certain group of doctors as Lundbeck prepares to market its new pill against alcohol dependence.
by Kresten Morten Munksgaard
First depth, then width, seems to be Lundbeck’s marketing tactic for its new alcohol drug, Selincro. The pill has just been launched in Norway, Poland, Finland and the Baltic countries and during the course of this year the presence of the drug is to be expanded further.
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
